These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

737 related articles for article (PubMed ID: 16908914)

  • 21. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation incorporating both cystatin C and creatinine best predicts individual risk: a cohort study in 444 patients with chronic kidney disease.
    Rogacev KS; Pickering JW; Seiler S; Zawada AM; Emrich I; Fliser D; Heine GH
    Nephrol Dial Transplant; 2014 Feb; 29(2):348-55. PubMed ID: 24166454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimation of Glomerular Filtration Rate in Elderly Chronic Kidney Disease Patients: Comparison of Three Novel Sophisticated Equations and Simple Cystatin C Equation.
    Bevc S; Hojs N; Hojs R; Ekart R; Gorenjak M; Puklavec L
    Ther Apher Dial; 2017 Apr; 21(2):126-132. PubMed ID: 28296256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between chronic kidney disease detected using creatinine and cystatin C and death and cardiovascular events in elderly Mexican Americans: the Sacramento Area Latino Study on Aging.
    Peralta CA; Lee A; Odden MC; Lopez L; Zeki Al Hazzouri A; Neuhaus J; Haan MN
    J Am Geriatr Soc; 2013 Jan; 61(1):90-5. PubMed ID: 23252993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two novel equations to estimate kidney function in persons aged 70 years or older.
    Schaeffner ES; Ebert N; Delanaye P; Frei U; Gaedeke J; Jakob O; Kuhlmann MK; Schuchardt M; Tölle M; Ziebig R; van der Giet M; Martus P
    Ann Intern Med; 2012 Oct; 157(7):471-81. PubMed ID: 23027318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pretransplant renal function according to CKD-EPI cystatin C equation is a prognostic factor of death after liver transplantation.
    Uguen T; Jezequel C; Ropert M; Houssel-Debry P; Latournerie M; Lainé F; Deugnier Y; Vigneau C; Boudjema K; Guyader D; Bardou-Jacquet E
    Liver Int; 2016 Apr; 36(4):547-54. PubMed ID: 26502295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation and application of estimation of glomerular filtration rate based on serum creatinine and cystatin C in renal function staging].
    Shen ZX; Liu Y; Liu M; Zheng H; Wu XJ; Shen C
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Nov; 38(11):1557-1562. PubMed ID: 29141349
    [No Abstract]   [Full Text] [Related]  

  • 27. Circulating Cystatin C Is an Independent Risk Marker for Cardiovascular Outcomes, Development of Renal Impairment, and Long-Term Mortality in Patients With Stable Coronary Heart Disease: The LIPID Study.
    West M; Kirby A; Stewart RA; Blankenberg S; Sullivan D; White HD; Hunt D; Marschner I; Janus E; Kritharides L; Watts GF; Simes J; Tonkin AM;
    J Am Heart Assoc; 2022 Mar; 11(5):e020745. PubMed ID: 35179040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study.
    Keller CR; Odden MC; Fried LF; Newman AB; Angleman S; Green CA; Cummings SR; Harris TB; Shlipak MG
    Kidney Int; 2007 Feb; 71(3):239-44. PubMed ID: 17183246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of cystatin C levels in estimating renal function and prognosis in patients with chronic systolic heart failure.
    Damman K; van der Harst P; Smilde TD; Voors AA; Navis G; van Veldhuisen DJ; Hillege HL
    Heart; 2012 Feb; 98(4):319-24. PubMed ID: 22038544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shrunken pore syndrome and mortality: a cohort study of patients with measured GFR and known comorbidities.
    Åkesson A; Lindström V; Nyman U; Jonsson M; Abrahamson M; Christensson A; Björk J; Grubb A
    Scand J Clin Lab Invest; 2020 Sep; 80(5):412-422. PubMed ID: 32459111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
    Potok OA; Ix JH; Shlipak MG; Katz R; Hawfield AT; Rocco MV; Ambrosius WT; Cho ME; Pajewski NM; Rastogi A; Rifkin DE
    Am J Kidney Dis; 2020 Dec; 76(6):765-774. PubMed ID: 32682697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cystatin C identifies cardiovascular risk better than creatinine-based estimates of glomerular filtration in middle-aged individuals without a history of cardiovascular disease.
    Svensson-Färbom P; Ohlson Andersson M; Almgren P; Hedblad B; Engström G; Persson M; Christensson A; Melander O
    J Intern Med; 2014 May; 275(5):506-21. PubMed ID: 24279862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the clinical application of cystatin C, a new marker of the glomerular filtration rate, for the initial dose-setting of arbekacin.
    Otsuka T; Tanaka A; Suemaru K; Inoue T; Nishimiya T; Murase M; Araki H
    J Clin Pharm Ther; 2008 Jun; 33(3):227-35. PubMed ID: 18452409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cystatin-C and mortality in elderly persons with heart failure.
    Shlipak MG; Katz R; Fried LF; Jenny NS; Stehman-Breen C; Newman AB; Siscovick D; Psaty BM; Sarnak MJ
    J Am Coll Cardiol; 2005 Jan; 45(2):268-71. PubMed ID: 15653026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Creatinine clearance, Cockcroft-Gault formula and cystatin C: estimators of true glomerular filtration rate in the elderly?
    Burkhardt H; Bojarsky G; Gretz N; Gladisch R
    Gerontology; 2002; 48(3):140-6. PubMed ID: 11961366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of a cystatin C gene variant with cystatin C levels, CKD, and risk of incident cardiovascular disease and mortality.
    O'Seaghdha CM; Tin A; Yang Q; Katz R; Liu Y; Harris T; Astor B; Coresh J; Fox CS; Kao WH; Shlipak MG
    Am J Kidney Dis; 2014 Jan; 63(1):16-22. PubMed ID: 23932088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glomerular filtration rate estimation in patients with advanced chronic renal insufficiency based on serum cystatin C levels.
    Schück O; Teplan V; Jabor A; Stollova M; Skibova J
    Nephron Clin Pract; 2003; 93(4):c146-51. PubMed ID: 12759583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study of cystatin C and serum creatinine in the estimative of glomerular filtration rate in children.
    Cordeiro VF; Pinheiro DC; Silva GB; Lima JW; Mota RM; Libório AB; Daher EF
    Clin Chim Acta; 2008 May; 391(1-2):46-50. PubMed ID: 18298952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimation of glomerular filtration rate in the elderly: a comparison of creatinine-based formulae with serum cystatin C.
    Wasén E; Isoaho R; Mattila K; Vahlberg T; Kivelä SL; Irjala K
    J Intern Med; 2004 Jul; 256(1):70-8. PubMed ID: 15189368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Intra-individual Differences in Estimated GFR by Creatinine Versus Cystatin C With Incident Heart Failure.
    Chen DC; Shlipak MG; Scherzer R; Bansal N; Potok OA; Rifkin DE; Ix JH; Muiru AN; Hsu CY; Estrella MM
    Am J Kidney Dis; 2022 Dec; 80(6):762-772.e1. PubMed ID: 35817274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.